Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 5/20 | 0.46 |
| ▸ | ADH1A | P07327 | 5/20 | 0.46 |
| ▸ | ADH7 | P40394 | 4/20 | 0.46 |
| ▸ | ADH1C | P00326 | 4/20 | 0.46 |
| ▸ | ADH4 | P08319 | 2/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.32 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.32 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.32 |
| ▸ | ANPEP | P15144 | 1/20 | 0.31 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.31 |
| ▸ | RRM1 | P23921 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15241553 | 0.82 | ADH1B (0.50) | ADH1BADH1AADH7ADH1CADH4 | |
| SCHEMBL3609608 | 0.79 | ADH1B (0.48) | ADH1BADH1AADH7ADH1CADH4 | |
| SCHEMBL13624944 | 0.77 | TSHR (0.42) | TRPV1TRPA1 | |
| SCHEMBL11413206 | 0.76 | ADH1B (0.50) | ADH1BADH1AADH7ADH1CADH4 | |
| SCHEMBL12519632 | 0.76 | ADH1B (0.50) | ADH1BADH1AADH7ADH1CADH4 | |
| SCHEMBL10798330 | 0.75 | TRPV1 (0.50) | TRPV1TRPA1 | |
| SCHEMBL979732 | 0.75 | ADH1B (0.72) | ADH1BADH1AADH7ADH1CADH4 | |
| SCHEMBL27635113 | 0.75 | ADH1B (0.72) | ADH1BADH1AADH7ADH1CADH4 | |
| SCHEMBL11322360 | 0.75 | ADH1B (0.72) | ADH1BADH1AADH7ADH1CADH4 | |
| SCHEMBL8764004 | 0.75 | ADH1B (0.72) | ADH1BADH1AADH7ADH1CADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4212552-A1 | ANTI-HER2 ANTIBODY-DRUG CONJUGATE | Daiichi Sankyo Company, Limited (JP) | 2023-07-19 | — | — | EP | disclosed |